These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16217299)

  • 1. The association of body mass index and prostate-specific antigen in a population-based study.
    Walsh PC
    J Urol; 2005 Nov; 174(5):1825. PubMed ID: 16217299
    [No Abstract]   [Full Text] [Related]  

  • 2. Observed effect of age and body mass index on total and complexed PSA: analysis from a National Screening Program.
    Walsh PC
    J Urol; 2005 Nov; 174(5):1825-6. PubMed ID: 16217298
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance in healthy men of the association between obesity related plasma hemodilution and tumor marker concentration.
    Chang IH; Ahn SH; Han JH; Kim TH; Kim YS; Myung SC
    J Urol; 2009 Feb; 181(2):567-72; discussion 572-3. PubMed ID: 19084848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
    Hutterer G; Perrotte P; Gallina A; Walz J; Jeldres C; Traumann M; Suardi N; Saad F; Bénard F; Valiquette L; McCormack M; Graefen M; Montorsi F; Karakiewicz PI
    Eur J Cancer; 2007 May; 43(7):1180-7. PubMed ID: 17292604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 men.
    Capitanio U; Perrotte P; Hutterer GC; Suardi N; Jeldres C; Shariat SF; Duclos A; Arjane P; Montorsi F; Karakiewicz PI
    Int J Urol; 2009 Jan; 16(1):91-5. PubMed ID: 19054167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prostate-specific membrane antigen and its role in diagnosis of prostate cancer].
    Chekhonin VP; Grigor'ev ME; Zhirkov IuA; Lebedev DV
    Vopr Med Khim; 2002; 48(1):31-43. PubMed ID: 12068496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of serum and urinary myeloid related protein-14 as a marker for early detection of prostate cancer.
    Müller H; Haug U; Rothenbacher D; Stegmaier C; Brenner H
    J Urol; 2008 Oct; 180(4):1309-12; discussion 1312-3. PubMed ID: 18707695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate screening in patients with 46,XY disorders of sex development--is it necessary?
    Salmasi AH; Wisniewski AB; Novak TE; Gearhart JP; Migeon CJ; Lakshmanan Y
    J Urol; 2008 Oct; 180(4):1422-5; discussion 1425-6. PubMed ID: 18710761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916.
    Montgomery RB; Goldman B; Tangen CM; Hussain M; Petrylak DP; Page S; Klein EA; Crawford ED;
    J Urol; 2007 Nov; 178(5):1946-51; discussion 1951. PubMed ID: 17868721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
    Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
    Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining increased future risk for prostate cancer: evidence from a population based screening cohort.
    Schröder FH; Roobol MJ; Andriole GL; Fleshner N
    J Urol; 2009 Jan; 181(1):69-74; discussion 74. PubMed ID: 19012915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostate-specific antigen--the most important cancer marker. Diagnostics and follow up of prostatic cancer have changed].
    Bratt O; Björk T
    Lakartidningen; 2007 Nov 14-20; 104(46):3460-4. PubMed ID: 18072615
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate-specific antigen in black men.
    Catalona WJ
    N Engl J Med; 1997 Jan; 336(2):134-5; author reply 135-6. PubMed ID: 8992341
    [No Abstract]   [Full Text] [Related]  

  • 15. Japanese Urological Association guidelines on prostate-specific antigen-based screening for prostate cancer and the ongoing cluster cohort study in Japan.
    Ito K; Kakehi Y; Naito S; Okuyama A;
    Int J Urol; 2008 Sep; 15(9):763-8. PubMed ID: 18786203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening.
    Moul JW; Sun L; Hotaling JM; Fitzsimons NJ; Polascik TJ; Robertson CN; Dahm P; Anscher MS; Mouraviev V; Pappas PA; Albala DM
    J Urol; 2007 Feb; 177(2):499-503; discussion 503-4. PubMed ID: 17222618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial comment. Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening.
    Bañez LL
    Urology; 2010 Nov; 76(5):e4. PubMed ID: 21056250
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study.
    Chia SE; Lau WK; Chin CM; Tan J; Ho SH; Lee J; Cheng C
    BJU Int; 2009 Jun; 103(11):1487-91. PubMed ID: 19076145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does body mass index affect preoperative prostate specific antigen velocity or pathological outcomes after radical prostatectomy?
    Loeb S; Yu X; Nadler RB; Roehl KA; Han M; Hawkins SA; Catalona WJ
    J Urol; 2007 Jan; 177(1):102-6; discussion 106. PubMed ID: 17162013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index and prostate specific antigen as predictors of adverse pathology and biochemical recurrence after prostatectomy.
    Bañez LL; Sun L; Trock BJ; Han M; Partin AW; Aronson WJ; Terris MK; Presti JC; Kane CJ; Amling CL; Moul JW; Freedland SJ
    J Urol; 2009 Aug; 182(2):491-6; discussion 496-8. PubMed ID: 19524974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.